Skip to content

Developing an ars moriendi nova in the face of the COVID-19 pandemic – a prospective mixed-methods survey

Developing an ars moriendi nova in the face of the COVID-19 pandemic – a prospective mixed-methods survey - ArsMoriendi-COVID

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023789
Enrollment
850
Registered
2020-12-18
Start date
2021-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any medical conditions that may exist U07.1

Interventions

Group 1: Observational study - Students and staff members of Freiburg University and Freiburg University Hospital complete a cross-sectional online survey and qualitative telephone interviews about th

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Staff members of two institutions with main work contract and including all status groups (scientific and non-scientific staff members, health care professionals involved in patient care at the university hospital), students of Freiburg University

Exclusion criteria

Exclusion criteria: Staff members and students not directly affiliated with Freiburg University or Freiburg University Hospital.

Design outcomes

Primary

MeasureTime frame
Changes in attitudes, behaviours and well-being, dealing with one’s own mortality during and through the Coronavirus pandemic (measured via validated, self-report questionnaires)

Secondary

MeasureTime frame
Self-reported experiences, attitudes and changes in these, reflection of one’s own mortality and dealing with one’s own finiteness during the Coronavirus pandemic (measured via semi-structured qualitative telephone interviews)

Countries

Germany

Contacts

Public ContactChristina Ramsenthaler

Klinik für Palliativmedizin, Universitätsklinikum Freiburg

christina.ramsenthaler@uniklinik-freiburg.de+49 761 270 94230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026